Uncoupling of inflammatory and destructive mechanisms in arthritis

Seminars in Arthritis and Rheumatism

Volumn 30, Issue 5 SUPPL. 2, 2001, Pages 7-16

  Van den Berg, Wim B ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cytokine pathways; IL 1; IL IRa; Rheumatoid arthritis; Tumor necrosis factor

Indexed keywords

CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ANTIBODY;

ARTICLE; CARTILAGE DEGENERATION; HUMAN; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

EID: 0035306510     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1053/sarh.2001.23704     Document Type: Article

References (30)

1. van den Berg WB, Joosten LA, Kollias G, van de Loo FA. Role of tumour necrosis factor alpha in experimental arthritis: Separate activity of interleukin 1beta in chronicity and cartilage destruction. Ann Rheum Dis 1999;58(suppl 1):140-8.
2. van den Berg WB, Bresnihan B. Pathogenesis of joint damage in rheumatoid arthritis: Evidence of a dominant role for interleukin-i. Baillieres Best Pract Res Clin Rheumatol 1999; 13:577-97.
3. van de Loo AA, Arntz OJ, Otterness IG, van den Berg WB. Protection against cartilage proteoglycan synthesis inhibition by anti-IL-1 antibodies in experimental arthritis. J Rheumatol 1992;19:348-56.
4. Henderson B, Pettipher ER. Arthritogenic actions of recombinant IL-1 and tumour necrosis factor alpha in the rabbit: Evidence for synergistic interactions between cytokines in vivo. Clin Exp Immunol 1989;75:306-10.
5. van de Loo AA, van den Berg WB. Effects of murine recombinant IL-1 on synovial joints in mice; measurement of patellar cartilage metabolism and joint inflammation. Ann Rheum Dis 1990;49:238-45.
6. Ghivizzani SC, Kang R, Georgescu, Lechman ER, Jaffurs D, Engle JM, et al. Constitutive intraarticular expression of IL-1b following gene transfer to rabbit synovium produces all major pathologies of human RA. J Immunol 1997;159:3604-12.
7. Probert L, Plows D, Kontogeorgos G, Kollias G. The type I interleukin-1 receptor acts in series with tumor necrosis factor (TNF) to induce arthritis in tnf-transgenic mice. Eur J Immunol 1995;25:1794-7.
8. Yasuo N, Harumoto Y, Toshiyuki K, et al. Membrane associated IL-1 contributes to chronic synovitis in human IL-1ra transgenic mice (abstr). Arthritis Rheum 1998:41:S212.
9. van de Loo AA, Joosten LA, van Lent PL, Arntz OJ, van den Berg WB. Role of IL-1, TNF and IL-6 in cartilage proteoglycan metabolism and destruction. Effect of in situ cytokine blocking in murine antigen and zymosan induced arthritis. Arthritis Rheum 1995;38:164-72.
10. van de Loo AA, Arntz OJ, Bakker AC, van Lent PL, Jacobs MJ, van den Berg WB. Role of IL-1 in antigen induced exacerbations of murine arthritis. Am J Pathol 1995;146:239-49.
11. Ghivizzani SC, Lechman ER, Kang R, Tio C, Kolls J, Evans CH, et al. Direct adenovirus-mediated gene transfer of interleukin 1 and tumor necrosis factor alpha soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects. Proc Natl Acad Sci U S A 1998;95:4613-8.
12. Kuiper S, Joosten LA, Bendele AM, Edwards CK, Arntz OJ, Helsen MM, et al. Different roles of tumour necrosis factor alpha and interleukin 1 in murine streptococcal cell wall arthritis. Cytokine 1998;10:690-702.
13. van den Berg WB, Joosten LA, van de Loo FA. TNF alpha and IL-1 beta are separate targets in chronic arthritis. Clin Exp Rheumatol 1999;17(6 Suppl 18):S105-14.
14. Joosten LA, Helsen MM, Saxne T, van de Loo FA, Heinegard D, van den Berg WB. IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas tnf-alpha blockade only ameliorates joint inflammation. J Immunol 1999;163:5049-55.
15. Feige U, Hu YL, Campagnuolo G, Munyakazi L, Bolon B. Anti-IL-1 and anti-TNF synergistically inhibit adjuvant arthritis in Lewis rats. Cell Mol Life Sci 2000;57;1457-70.
16. van den Berg WB. Arguments for IL-1 as a target in chronic arthritis. Ann Rheum Dis 2000;59(Suppl 1):81-4.
17. Joosten LAB, Helsen MMA, van de Loo AAJ, van den Berg WB. Anti-cytokine treatment of established type II collagen induced arthritis in DBA/1 mice: A comparative study using anti-TNF, anti-IL-1 and IL-1ra. Arthritis Rheum 1996;39:797-809.
18. van Lent PL, van de Loo AA, Holthuysen AE, van den Bersselaar LEM, Vermeer H, van den Berg WB. Major role for IL-1 but not for TNF in early cartilage damage in immune complex arthritis in mice. J Rheumatol 1995;22:2250-8.
19. Van Meurs JB, van Lent PL, Holthuysen AE, Bayne E, Singer II, van den Berg WB. Kinetics of aggrecanase and metalloproteinase induced neoepitopes in various stages of cartilage destruction in murine arthritis. Arthritis Rheum 1999; 42:1128-39.
20. van Meurs JB, van Lent PL, Holthuysen A, Lambrou D, Bayne E, Singer I, et al. Active matrix metalloproteinases are present in cartilage during immune complex-mediated arthritis: A pivotal role for stromelysin-1 in cartilage destruction. J Immunol 1999;163:5633-9.
21. van Meurs JB, van Lent PL, Stoop R, Holthuysen A, Singer I, Bayne E, et al. Cleavage of aggrecanase at the Asn341-Phe342 site coincides with the initiation of collagen damage in murine antigen-induced arthritis: A pivotal role for stromelysin 1 in matrix metalloproteinase activity. Arthritis Rheum 1999;42:2074-84.
22. van Meurs JB, van Lent PL, Singer II, Bayne EK, van de Loo AAJ, van den Berg WB. IL-1ra prevents expression of the metalloproteinase-generated neoepitope VDIPEN in antigen-induced arthritis. Arthritis Rheum 1998;41:647-56.
23. Barrera P, Joosten LA, den Broeder A, van de Putte LB, van Riel PL, van den Berg WB. Effect of therapy with a fully human anti-TNF monoclonal antibody on the local and systemic homeostasis of IL-1 and TNF in patients with RA. Ann Rheum Dis (in press).
24. Joosten LA, Ootes L, den Broeder A, van de Putte LB, Barrera P, van den Berg WB. Variations in IL-17, IL-1 and TNF expression patterns in synovial biopsies of active RA patients. Arthritis Rheum 2000;43:S83.
25. Chabaud M, Durand JM, Buchs N, Fossiez F, Page G, Frappart L, et al. Human interleukin-17: A T cell-derived proin-flammatory cytokine produced by the rheumatoid synovium. Arthritis Rheum 1999;42:963-70.
26. Lubberts E, Joosten LA, van de Loo AA, van den BersseLAar LA, van den Berg WB. Reduction of IL-17 induced inhibition of chondrocyte proteoglycan synthesis in intact murine articular cartilage by IL-4. Arthritis Rheum 2000;43: 1300-6.
27. Glansbeek HL, van Beuningen HM, Vitters EL, van der Kraan PM, van den Berg WB. Stimulation of articular cartilage repair in established arthritis by local administration of TGFβ into murine knee joints. Lab Invest 1998;78:133-42.
28. Lubberts E, Joosten LA, van den Bersselaar L, Helsen MM, Bakker AC, van Meurs JB, et al. Adenoviral vectormediated overexpression of IL-4 in the knee joint of mice with collagen-induced arthritis prevents cartilage destruction. J Immunol 1999;163:4546-56.
29. Lubberts E, Joosten LAB, Richards CD, Miossec P, van den Berg WB. IL-4 gene therapy for collagen arthritis suppresses IL-17 and OPG-L and prevents bone erosion. J Clin Invest 2000;105:1697-710.
30. Horai R, Saijo S, Tanioka H, Nakae S, Sudo K, Okahara A, et al. Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice. J Exp Med 2000;191:313-20.